Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paris polyphylla detoxification tincture real-world study for herpes zoster
ChiCTR2600130965Phase 4Not yet recruiting
- Sponsor
- Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
- Start
- Oct 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Paris polyphylla detoxification tincture in herpes zoster (HZ) (2 arms), sponsored by Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital. Primary endpoints: Herpes evaluation indicators, Pain assessment indicators and 2 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
Paris polyphylla detoxification tincture
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2600130965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130965.